Skip to main navigation
About
News & Events
News Releases
Events
Annual Meeting
Results
Stock Information
Stock Quote & Chart
Analyst Coverage
Regulated Information
Governance
Governance Documents
Management
Board of Directors
Whistleblower
IR Resources
Investor FAQs
Contact IR
Email Alerts
About
News Releases
Events
Annual Meeting
Results
Stock Quote & Chart
Analyst Coverage
Regulated Information
Governance Documents
Management
Board of Directors
Whistleblower
Investor FAQs
Contact IR
Email Alerts

Our Ambition

Build a global best-in-class beauty and wellness multi-brand platform by creating, acquiring, accelerating, and scaling the next generation of high-growth, purpose-driven brands.

Fiscal Year 2025 KEY HIGHLIGHTS

$272.1M net revenue
$194.7M adj. gross profit
$16.1M Adj. Ebitda
Results

Events

Latest Event
Waldencast plc First Quarter Fiscal 2025 Earnings Call
May 14, 2025 8:30 AM EDT
Latest Event
Waldencast plc Fourth Quarter Fiscal 2024 Earnings Call
March 19, 2025 8:30 AM EDT
All Events

Press Releases

Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
March 24, 2026
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
March 19, 2026
All Press Releases

Stock Chart

Stock Information

Minimum 15 minutes delayed. Source: LSEG

Our Brands

Milk Makeup

Milk Makeup

Obagi Medical

Obagi Medical

contact investor relations

Investors
ICR

Allison Malkin

waldencastir@icrinc.com

Media
ICR

Brittany Fraser

waldencastir@icrinc.com

Subscribe for updates

About
Our Brands
Newsroom
Investors
Contact
Cookie Policy
Privacy Policy
Waldencast Ventures